Oriola-KD Oyj B (OKDBV) - Net Assets

Latest as of March 2025: €132.60 Million EUR ≈ $155.02 Million USD

Based on the latest financial reports, Oriola-KD Oyj B (OKDBV) has net assets worth €132.60 Million EUR (≈ $155.02 Million USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€963.50 Million ≈ $1.13 Billion USD) and total liabilities (€830.90 Million ≈ $971.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Oriola-KD Oyj B to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets €132.60 Million
% of Total Assets 13.76%
Annual Growth Rate -1.6%
5-Year Change -21.34%
10-Year Change -31.45%
Growth Volatility 26.61

Oriola-KD Oyj B - Net Assets Trend (2004–2024)

This chart illustrates how Oriola-KD Oyj B's net assets have evolved over time, based on quarterly financial data. Also explore Oriola-KD Oyj B balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Oriola-KD Oyj B (2004–2024)

The table below shows the annual net assets of Oriola-KD Oyj B from 2004 to 2024. For live valuation and market cap data, see how much is Oriola-KD Oyj B worth.

Year Net Assets Change
2024-12-31 €133.40 Million
≈ $155.96 Million
-22.12%
2023-12-31 €171.30 Million
≈ $200.27 Million
-24.07%
2022-12-31 €225.60 Million
≈ $263.75 Million
+4.06%
2021-12-31 €216.80 Million
≈ $253.46 Million
+27.83%
2020-12-31 €169.60 Million
≈ $198.28 Million
+7.89%
2019-12-31 €157.20 Million
≈ $183.78 Million
-13.39%
2018-12-31 €181.50 Million
≈ $212.19 Million
-8.19%
2017-12-31 €197.70 Million
≈ $231.13 Million
-3.65%
2016-12-31 €205.20 Million
≈ $239.90 Million
+5.45%
2015-12-31 €194.60 Million
≈ $227.51 Million
+71.30%
2014-12-31 €113.60 Million
≈ $132.81 Million
-59.15%
2013-12-31 €278.10 Million
≈ $325.13 Million
-11.69%
2012-12-31 €314.90 Million
≈ $368.15 Million
+5.21%
2011-12-31 €299.30 Million
≈ $349.91 Million
-15.14%
2010-12-31 €352.70 Million
≈ $412.34 Million
+33.09%
2009-12-31 €265.00 Million
≈ $309.81 Million
+42.86%
2008-12-31 €185.50 Million
≈ $216.87 Million
-8.89%
2007-12-31 €203.60 Million
≈ $238.03 Million
+6.15%
2006-12-31 €191.80 Million
≈ $224.23 Million
+2.95%
2005-12-31 €186.30 Million
≈ $217.80 Million
+1.09%
2004-12-31 €184.30 Million
≈ $215.47 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Oriola-KD Oyj B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1820000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings €18.20 Million 13.64%
Other Components €115.20 Million 86.36%
Total Equity €133.40 Million 100.00%

Oriola-KD Oyj B Competitors by Market Cap

The table below lists competitors of Oriola-KD Oyj B ranked by their market capitalization.

Company Market Cap
Smith-Midland Corp
NASDAQ:SMID
$165.56 Million
Revival Gold Inc
V:RVG
$165.59 Million
Sunjin
KO:136490
$165.66 Million
InfuSystems Holdings Inc
NYSE MKT:INFU
$165.69 Million
KABE Group AB (publ.)
ST:KABE-B
$165.43 Million
A Paradise Acquisition Corp.
NYSE:APAD
$165.42 Million
Gozde Girisim Sermayesi Yatirim Ortakligi AS
IS:GOZDE
$165.39 Million
Element 29 Resources Inc
V:ECU
$165.36 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Oriola-KD Oyj B's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 171,300,000 to 133,400,000, a change of -37,900,000 (-22.1%).
  • Net loss of 20,100,000 reduced equity.
  • Dividend payments of 12,700,000 reduced retained earnings.
  • Share repurchases of 100,000 reduced equity.
  • Other comprehensive income decreased equity by 84,200,000.
  • Other factors increased equity by 79,200,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €-20.10 Million -15.07%
Dividends Paid €12.70 Million -9.52%
Share Repurchases €100.00K -0.07%
Other Comprehensive Income €-84.20 Million -63.12%
Other Changes €79.20 Million +59.37%
Total Change €- -22.12%

Book Value vs Market Value Analysis

This analysis compares Oriola-KD Oyj B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.51x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.85x to 1.51x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 €1.30 €1.11 x
2007-12-31 €1.38 €1.11 x
2008-12-31 €1.30 €1.11 x
2009-12-31 €1.66 €1.11 x
2010-12-31 €2.33 €1.11 x
2011-12-31 €1.98 €1.11 x
2012-12-31 €2.08 €1.11 x
2013-12-31 €1.84 €1.11 x
2014-12-31 €0.71 €1.11 x
2015-12-31 €1.10 €1.11 x
2016-12-31 €1.13 €1.11 x
2017-12-31 €1.09 €1.11 x
2018-12-31 €1.00 €1.11 x
2019-12-31 €0.87 €1.11 x
2020-12-31 €0.93 €1.11 x
2021-12-31 €1.20 €1.11 x
2022-12-31 €1.24 €1.11 x
2023-12-31 €0.94 €1.11 x
2024-12-31 €0.74 €1.11 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Oriola-KD Oyj B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -15.07%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1.20%
  • • Asset Turnover: 1.92x
  • • Equity Multiplier: 6.56x
  • Recent ROE (-15.07%) is below the historical average (-2.01%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 10.11% 1.29% 2.18x 3.61x €190.00K
2006 5.24% 1.45% 1.08x 3.34x €-8.72 Million
2007 11.92% 1.69% 2.13x 3.30x €3.75 Million
2008 14.99% 1.74% 2.00x 4.31x €9.15 Million
2009 19.97% 2.84% 1.86x 3.79x €24.26 Million
2010 28.95% 5.29% 1.62x 3.38x €66.83 Million
2011 -8.05% -1.12% 1.69x 4.25x €-54.03 Million
2012 5.46% 0.70% 1.88x 4.19x €-14.29 Million
2013 2.09% 0.22% 1.73x 5.39x €-22.01 Million
2014 -186.88% -13.17% 1.84x 7.69x €-223.66 Million
2015 22.92% 2.74% 1.72x 4.87x €25.14 Million
2016 20.86% 2.61% 1.77x 4.51x €22.28 Million
2017 13.30% 1.72% 1.66x 4.67x €6.53 Million
2018 7.00% 0.82% 1.67x 5.11x €-5.45 Million
2019 5.09% 0.46% 1.67x 6.56x €-7.72 Million
2020 6.66% 0.63% 1.54x 6.87x €-5.66 Million
2021 5.21% 0.60% 1.72x 5.04x €-10.38 Million
2022 2.13% 0.32% 1.58x 4.26x €-17.76 Million
2023 -12.08% -1.39% 1.60x 5.46x €-37.83 Million
2024 -15.07% -1.20% 1.92x 6.56x €-33.44 Million

Industry Comparison

This section compares Oriola-KD Oyj B's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

Industry Context

  • Industry: Pharmaceutical Retailers
  • Average net assets among peers: $113,600,000
  • Average return on equity (ROE) among peers: -186.88%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Oriola-KD Oyj B (OKDBV) €132.60 Million 10.11% 6.27x $165.45 Million
Oriola-KD Oyj A (OKDAV) $113.60 Million -186.88% 6.69x $64.02 Million

About Oriola-KD Oyj B

HE:OKDBV Finland Pharmaceutical Retailers
Market Cap
$165.45 Million
€141.52 Million EUR
Market Cap Rank
#17388 Global
#76 in Finland
Share Price
€1.11
Change (1 day)
+0.00%
52-Week Range
€1.11 - €1.11
All Time High
€3.41
About

Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed… Read more